Q3 2017 EARNINGS RELEASE 8-K

Company

ENANTA PHARMACEUTICALS INC

Filed

August 7, 2017

Period of Report

August 7, 2017

Accession Number

0001564590-17-015996

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →